Ewa Niżankowska

Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics

Barbro Dahlén, Ewa Niżankowska, A Szczeklik et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 395 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist: A Randomized, Double-Blind, Placebo-Controlled Trial

Sven‐Erik Dahlén, Kerstin Malmström, Ewa Niżankowska et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 317 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge

Grażyna Bochenek, Krzysztof Nagraba, Ewa Niżankowska et al. · Journal of Allergy and Clinical Immunology · 2003 · 159 citations · Full text

Medicine, Biochemistry, Pharmacology +13

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma

Mamert Milewski, Lucyna Mastalerz, Ewa Niżankowska et al. · Journal of Allergy and Clinical Immunology · 1998 · 147 citations

Life Sciences, Immunology, Pharmacology +14

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib

Pär Gyllfors, Grażyna Bochenek, John Overholt et al. · Journal of Allergy and Clinical Immunology · 2003 · 143 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9